Neurocognitive predictors of quality of life of patients with schizophrenia by Nuno Rocha et al.
Nuno Rocha ab, Cristina Queirós b, Susana Aguiar b & António Marques ab
Introduction
Recent investigations tried to establish a causal relationship between neurocognitive deficits and functional outcomes (Green et al., 2000). However, in studies that used quality 
of life as the primary functional variable, mixed results were found. In some studies associations with neurocognition were strong, but in others, the associations were week or 
inexistent (Alptekin et al., 2005; Fujii, Wylie & Nathan, 2004; Hofer et al., 2005; Sota & Heinrichs, 2004; Weneger et al., 2005). 
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Stepwise multiple regressions predicting Physical health, and amount of variance accounted for by neurocognitive 
variables (marked with red in the graphic)
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Neurocognitive parameter’s:
h Attention
h Visual-spatial organization and memory
h Working memory
h Speed processing
h Verbal Skills
h Social sequencing skills
h Arithmetic's and logical reasoning
h Executive functions
h General Intellectual ability
Quality of life: The WHOQOL-BREF instrument 
comprises 26 items, which measure the following 
broad domains:
h Physical health
h Psychological health
h Social relationships
h Environment 
Sample consisted of 37 individuals diagnosed with schizophrenia. All subjects 
were assessed with a battery of neurocognitive tests (WCST, WAIS-III selected 
subtests, Stroop Test, Rey Figure Complex Test, d2 Attention Test, IA Test). 
For the assessment of quality of life, we used the WHOQOL – Portuguese 
Version (Vaz-Serra et al., 2006). We performed stepwise multiple regression 
analysis, in order to determine predictive models of quality of life.
Methods
Purpose
The purpose of this study was to examine the impact and interference of neurocognitive impairment in different aspects of the quality of life of patients with schizophrenia. To 
achieve this goal, we tried to identify differential neurocognitive predictors of discrete quality of life domains, and to calculate the amount of explained variance accounted for by 
neurocognitive variables.
(df) F sig. R2 β T sr2 sig.
Global Model (1,35) 9.540 0.004** 0.214
Predictors
% Perseverative Errors -0.463 -3.089 0.214 0.004**
Stepwise multiple regressions predicting Psychological health, and amount of variance accounted for by neurocognitive 
variables (marked with red in the graphic)
(df) F sig. R2 β T sr2 sig.
Global Model (2,34) 16.200 0.000*** 0.488
Predictors
Rey – Copy 0.445 3.309 0.165 0.002**
Total Score d2 Test 0.387 2.882 0.125 0.007**
Stepwise multiple regressions predicting Social relationships and amount of variance accounted for by neurocognitive 
variables (marked with red in the graphic)
(df) F sig. R2 β T sr2 sig.
Global Model (2,34) 12.099 0.000*** 0.416
Predictors
Total Score d2 Test 0.410 2.860 0.141 0.007**
Rey - Copy 0.357 2.491 0.106 0.018*
(df) F sig. R2 β T sr2 sig.
Global Model (2,34) 8.505 0.001*** 0.333
Predictors
Stroop-Colors 0.358 2.336 0.107 0.026*
% Perseverative Errors -0.331 -2.163 0.092 0.038*
Stepwise multiple regressions predicting the Environment dimension and amount of variance accounted for by 
neurocognitive variables (marked with red in the graphic)
There were significant correlations between most of the neurocognitive constructs and quality of life. Predictive models explained 21% to 49% of the variance in the 
domains of quality of life that we considered. Significant neurocognitive predictors were the following: for the Physical domain, the executive functions; for the 
Psychological and Social Relations domains, attention and visual-spatial organization; and for the Environmental domain, the executive functions and attention. These 
results highlight the need to work the cognitive deficits in order to promote the quality of life of persons with schizophrenia.
* p<0.050    ** p<0.010   *** p<0.001
* p<0.050    ** p<0.010   *** p<0.001
